What is the recommended dosage of doxycycline (tetracycline antibiotic) for an adult patient with no significant medical history and normal renal (kidney function) and hepatic (liver function) for the treatment of a soft tissue infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline Dosing for Soft Tissue Infections

For an adult with normal renal and hepatic function and a soft tissue infection, doxycycline should be dosed at 100 mg orally twice daily (BID). 1

Standard Dosing Regimen

  • Dose: 100 mg orally twice daily 1
  • Duration: 7-10 days, depending on clinical response 1
  • Route: Can be given orally or intravenously at the same dose 1

When Doxycycline is Appropriate for Soft Tissue Infections

Doxycycline is not a first-line agent for most common soft tissue infections (cellulitis, abscesses). However, it has specific roles:

Recommended Scenarios:

  • Purulent cellulitis with suspected MRSA: Doxycycline is a guideline-recommended option when methicillin-resistant Staphylococcus aureus is suspected, particularly in outpatients with purulent drainage 1, 2
  • Mild tularemia: 100 mg BID orally is specifically recommended 1
  • Bubonic plague: 100 mg BID orally is an alternative to streptomycin 1
  • Bacillary angiomatosis: 100 mg BID for 2 weeks to 2 months 1
  • Bioterrorism-related cutaneous anthrax: 100 mg BID for 60 days 1

Coverage Profile:

  • Good activity against: Eikenella species, staphylococci (including many MRSA strains), and anaerobes 1
  • Limited activity: Some streptococci are resistant 1
  • Does NOT cover: Beta-hemolytic streptococci reliably 1

Critical Clinical Decision Point

If the infection is non-purulent cellulitis (no drainage, no abscess), doxycycline is NOT appropriate as monotherapy because beta-hemolytic streptococci are the primary pathogens and may be resistant. 1

For non-purulent cellulitis, use:

  • Cephalexin 500 mg four times daily, OR
  • Cefazolin 1 g IV every 8 hours 1, 3

If you need coverage for both streptococci AND MRSA (purulent cellulitis in areas with high MRSA prevalence):

  • Doxycycline 100 mg BID PLUS a beta-lactam (e.g., amoxicillin), OR
  • Use clindamycin or linezolid alone 1

Important Contraindications and Caveats

  • Do not use in children <8 years of age due to permanent tooth discoloration and decreased bone growth 1, 4
  • Avoid in pregnancy (Category D medication) 4
  • Not for bite wounds: Use amoxicillin-clavulanate instead, as doxycycline misses important bite-related pathogens 5
  • Not for necrotizing infections: These require broad-spectrum IV therapy (vancomycin plus piperacillin-tazobactam or carbapenems) and urgent surgical debridement 1, 5

Treatment Duration and Monitoring

  • Standard duration: 7-10 days for most soft tissue infections 1
  • Extended therapy: May be needed for specific conditions like bacillary angiomatosis (2 weeks to 2 months) 1
  • Clinical response expected: Within 48-72 hours; if no improvement, consider resistant organisms, deeper infection, or alternative diagnosis 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cephalexin Dosing and Clinical Considerations for Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on rosacea and anti-inflammatory-dose doxycycline.

Drugs of today (Barcelona, Spain : 1998), 2007

Guideline

Co-amoxiclav Dosing for Skin Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.